These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 12060400
1. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. Katz KA, Marcil I, Stern RS. J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400 [Abstract] [Full Text] [Related]
2. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. Lim JL, Stern RS. J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190 [Abstract] [Full Text] [Related]
3. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P. J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317 [Abstract] [Full Text] [Related]
4. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. Stern RS, Liebman EJ, Väkevä L. J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734 [Abstract] [Full Text] [Related]
5. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. Nijsten TE, Stern RS. J Invest Dermatol; 2003 Aug 02; 121(2):252-8. PubMed ID: 12880415 [Abstract] [Full Text] [Related]
6. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study. J Am Acad Dermatol; 2002 Jul 02; 47(1):33-9. PubMed ID: 12077578 [Abstract] [Full Text] [Related]
7. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients. Wolf P, Kreimer-Erlacher H, Seidl H, Bäck B, Soyer HP, Kerl H. J Invest Dermatol; 2004 Jan 02; 122(1):190-200. PubMed ID: 14962108 [Abstract] [Full Text] [Related]
8. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P. J Invest Dermatol; 2003 Apr 02; 120(4):676-82. PubMed ID: 12648234 [Abstract] [Full Text] [Related]
9. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L. J Invest Dermatol; 2003 Feb 02; 120(2):211-6. PubMed ID: 12542524 [Abstract] [Full Text] [Related]
10. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. Hannuksela-Svahn A, Pukkala E, Läärä E, Poikolainen K, Karvonen J. J Invest Dermatol; 2000 Mar 02; 114(3):587-90. PubMed ID: 10692122 [Abstract] [Full Text] [Related]
11. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. Stern RS, PUVA Follow-Up Study. J Am Acad Dermatol; 2012 Apr 02; 66(4):553-62. PubMed ID: 22264671 [Abstract] [Full Text] [Related]
12. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM. Arch Dermatol; 1995 Apr 02; 131(4):432-5. PubMed ID: 7726585 [Abstract] [Full Text] [Related]
13. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. Nijsten TE, Stern RS. J Am Acad Dermatol; 2003 Oct 02; 49(4):644-50. PubMed ID: 14512910 [Abstract] [Full Text] [Related]
14. Cutaneous squamous-cell carcinoma in patients treated with PUVA. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. N Engl J Med; 1984 May 03; 310(18):1156-61. PubMed ID: 6709010 [Abstract] [Full Text] [Related]
15. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. Asgari MM, Ray GT, Geier JL, Quesenberry CP. J Am Acad Dermatol; 2017 Apr 03; 76(4):632-638. PubMed ID: 28162854 [Abstract] [Full Text] [Related]
16. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Marcil I, Stern RS. Lancet; 2001 Sep 29; 358(9287):1042-5. PubMed ID: 11589933 [Abstract] [Full Text] [Related]
17. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L, Cesame Study Group. Gastroenterology; 2011 Nov 29; 141(5):1621-28.e1-5. PubMed ID: 21708105 [Abstract] [Full Text] [Related]
18. Nonmonoclonal PTCH gene mutations in psoralen plus UVA-associated basal cell carcinomas. Heitzer E, Wolf P. J Invest Dermatol; 2008 Mar 29; 128(3):746-9. PubMed ID: 18059486 [No Abstract] [Full Text] [Related]
19. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Flohil SC, Koljenović S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Br J Dermatol; 2011 Oct 29; 165(4):874-81. PubMed ID: 21711333 [Abstract] [Full Text] [Related]
20. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL. Cancer Epidemiol Biomarkers Prev; 1998 Feb 29; 7(2):157-61. PubMed ID: 9488591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]